Abstract
Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 996-1004 |
| Number of pages | 9 |
| Journal | Journal of Child and Adolescent Psychopharmacology |
| Volume | 15 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 2005 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Pharmacology (medical)
- Psychiatry and Mental health
- Pediatrics, Perinatology, and Child Health
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders. / Hah, Mina; Chang, Kiki.
In: Journal of Child and Adolescent Psychopharmacology, Vol. 15, No. 6, 12.2005, p. 996-1004.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders
AU - Hah, Mina
AU - Chang, Kiki
PY - 2005/12
Y1 - 2005/12
N2 - Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.
AB - Children and adolescents with bipolar disorder (BD) have a high incidence of comorbid attention-deficit/hyperactivity disorder (ADHD). In this paper, we report a consecutive case series on 7 patients with pediatric BD and ADHD who were treated with atomoxetine-and all but one were also treated in conjunction with mood stabilizers. All patients were outpatients at the Stanford Pediatric Bipolar Disorders Clinic. Information on patients was collected in a retrospective chart review. All but 1 patient demonstrated significant improvement in symptoms of ADHD. No patients had episodes of hypomania or mania during the treatment period. Adverse effects of atomoxetine treatment included sedation, nausea, and decreased appetite. These cases suggest that atomoxetine may be a safe and effective treatment for ADHD in conjunction with mood stabilizers in children with BD.
UR - http://www.scopus.com/inward/record.url?scp=29944443819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=29944443819&partnerID=8YFLogxK
U2 - 10.1089/cap.2005.15.996
DO - 10.1089/cap.2005.15.996
M3 - Article
C2 - 16379520
AN - SCOPUS:29944443819
VL - 15
SP - 996
EP - 1004
JO - Journal of Child and Adolescent Psychopharmacology
JF - Journal of Child and Adolescent Psychopharmacology
SN - 1044-5463
IS - 6
ER -